1.
Vaccine
; 29(5): 1053-71, 2011 Jan 29.
Artigo
em Inglês
| MEDLINE
| ID: mdl-21130754
2.
Southeast Asian J Trop Med Public Health
; 35(4): 954-8, 2004 Dec.
Artigo
em Inglês
| MEDLINE
| ID: mdl-15916097
RESUMO
We evaluated the CR326F strain (VAQTA) derived hepatitis A vaccine in Korean children and adolescents >2 years of age to consider a future immunization program. In our study, the pediatric two-dose regimen of VAQTA was found to be generally well tolerated and resulted in 100% (95% CI 94.8, 100.0) seroconversion after 2 doses. Immunizing children with the HAV vaccine routinely should be considered in South Korea, particularly in areas where recent outbreaks have occurred.